Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Sold as Westcort. Every FDA application for this active ingredient: 2 branded and 11 generic.
As of Nov 15, 2026, FDA lists 13 applications for Hydrocortisone Valerate (sold as Westcort), first approved Mar 17, 1978, with 0 new uses approved and 0 published complete response letters.
First approved: Mar 17, 1978
Applications: 13
New uses approved: 0
Complete response letters: 0
Medicare spending, 2025: $1.3M
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Product
Part
Spending, 2025
Change
Beneficiaries
Hydrocortisone Valerate
Part D
$1.3M
-1%
15,358
Clinical Trials
110 open or ongoing studies name this ingredient as an intervention, including as a comparator; newest first. See all
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA
Sun Pharm Inds Inc
Lupin